Emulating real-world GLP-1 efficacy in type 2 diabetes through causal learning and virtual patients.
MacLellan CR, Petkov H, McKeag C · PLOS digital health · 2025 · Article
10.1371/journal.pdig.0000927
Verified evidence
Model evaluation
106fd850-d5d9-55c2-ac2e-eef481fca240Prediction source Version of record · PDF page(s) 5
Study 6ba6ccf3-3034-5adb-8ace-81dba59a53ca · Prediction record (JSON)
Prediction fields
- Measured variable
- glycated_hemoglobin · PDF page(s) 5
Model scenario comparison
7ae614ad-a54a-55c0-b37b-2a18c3b97776Prediction source Version of record · PDF page(s) 5
Study 6ba6ccf3-3034-5adb-8ace-81dba59a53ca · Prediction record (JSON)
Prediction fields
- Concrete comparator
- GLP-1 emulation arm versus virtual placebo arm for the signed HbA1c reduction · PDF page(s) 5
- Measured variable
- glycated_hemoglobin · PDF page(s) 5
Validation Related evidence · Independent source · Unknown · Partial support · Partially comparable · Statistically significant